Advanced diagnostic centre and NABL- and NABH-accredited diagnostic centre Molecular Diagnostics and Therapy provides Anti-Phospholipid Profile (APLA) Test. This blood test helps detect certain antibodies that have been associated with a condition called antiphospholipid syndrome (APS), which increases the risk of abnormal blood clots in men and women, and of certain pregnancy complications in women. It facilitates the diagnosis for doctors looking into unexplained blood clots, recurrent pregnancy loss, and other signs and symptoms of antiphospholipid antibodies.
APLs are proteins secreted by the immune system that mistakenly attack some of the proteins that make up phospholipids, a part of a cell's membranes. In the body, they increase clotting risk. In the lab, they can prolong some clotting tests in some individuals. An antiphospholipid Profile may be used to help identify these antibodies and to help assess the presence of antiphospholipid syndrome. Some tests commonly included on the profile are for antibodies to cardiolipin, beta-2 glycoprotein I antibodies, and lupus anticoagulant. Panel components may vary from laboratory to laboratory.
This autoimmune disorder occurs alongside other clotting issues/complications in pregnancy and the presence of anti-phospholipid antibodies in blood layers. Knowing what type of antibody is present can aid diagnosis.
Clots occurring within deep blood vessels (usually in the legs) caused by thickening of blood. Those with anti-phospholipid antibodies are more susceptible to having blood clots.
Pulmonary Embolism is caused by a blood clot travelling to the lungs and blocking the pulmonary circulation. The APLA profile might be ordered to help decide if the deep vein thrombosis is caused by any underlying tendency to abnormal blood clotting.
Some pregnancy complications, like recurrent miscarriages and placental complications, are linked to persistent antiphospholipid antibodies. Tests can be used to gain clues to the possible cause of APS.
In some SLE patients, APAs can also be found. The profile can be useful in determining the presence of such antibodies and assessing the risk of associated clotting.
Combining Molecular Diagnostics and Therapy gives a joined-up diagnostic service between Radiology, Nuclear Medicine and Pathology. In testing for antibodies, strict protocols are followed from sample handling through to laboratory procedures and quality control. We deliver very detailed information on the results. We also provide detailed clinical information. This means we can provide accurate diagnosis and patient-centred care, giving physicians all the information required to allow them to understand the results in conjunction with clinical data.
To schedule an appointment for your Anti Phospholipid Profile test, please give our centre a call. Bring a prescription from your doctor, and any previous medical reports or test results about any clotting disorder, autoimmune problems, or pregnancy complications you may have had. Generally, it is not required, but it is important to inform the physician and blood testing facility that you are using blood-thinning medication, as some medications may affect lupus anticoagulant testing.
Test information: Fasting is generally not required.
Reporting: Within 24 hours*